-
Cryoport Systems achieves ISO 21973 certification for cell therapy transport
-
Cryoport opens 55,000-square-foot facility near Paris airport
-
KeyBanc: 'Cell & Gene Therapy Getting More Support; BLFS, CYRX, TKNO With the Most Exposure'
-
KeyBanc: 'Cell & Gene Therapy Getting More Support; BLFS, CYRX, TKNO With the Most Exposure'
-
CryoPort (CYRX) PT Raised to $15 at BTIG
-
Leerink Partners Upgrades CryoPort (CYRX) to Outperform
-
CryoPort (CYRX) PT Raised to $8 at Jefferies
-
KeyBanc Upgrades CryoPort (CYRX) to Overweight
-
Cryoport (CYRX) Tops Q2 EPS by $2.32, Beats on Revenue
-
Cryoport (CYRX) Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group
-
Cryoport (CYRX) Tops Q1 EPS by 3c, provides guidance
-
Needham Reiterates Buy Rating on CryoPort (CYRX)
-
CryoPort (CYRX) PT Raised to $11 at UBS
-
KeyBanc Reiterates Sector Weight on CryoPort (CYRX) Amid DHL Partnership & Asset Sale
-
Cryoport (CYRX) Sells CRYOPDP to DHL Group
-
UBS Upgrades CryoPort (CYRX) to Buy, 'Credible Growth Opportunity to Follow Well Understood Headwinds'
-
Cryoport (CYRX) launches MVE's High-Efficiency 800 C cryogenic freezer
-
CryoPort (CYRX) PT Lowered to $6.50 at Jefferies
-
Cryoport (CYRX) Misses Q4 EPS by 13c
-
Guggenheim Starts CryoPort (CYRX) at Buy
-
Cryoport (CYRX) Tops Q3 EPS by 30c ; Offers Guidance
-
CryoPort (CYRX) PT Lowered to $11 at Needham
-
Roth/MKM Reiterates Buy Rating on CryoPort (CYRX)
-
Jefferies Downgrades CryoPort (CYRX) to Hold
-
Cryoport (CYRX) Misses Q2 EPS by 123c ; Offers Guidance
-
Cryoport (CYRX) Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes
-
B.Riley Upgrades CryoPort (CYRX) to Buy

